Corcept Therapeutics Inc’s filing revealed that its Officer Guyer William acquired Company’s shares for reported $1.6 million on Dec 02 ’25. In the deal valued at $79.78 per share,20,000 shares were bought.
Then, BELANOFF JOSEPH K bought 40,000 shares, generating $3,176,000 in total proceeds.
Before that, Maduck Sean bought 20,000 shares. Corcept Therapeutics Inc shares valued at $1,588,000 were divested by the Officer at a price of $79.40 per share.
Wolfe Research initiated its Corcept Therapeutics Inc [CORT] rating to a Peer perform in a research note published recently. A number of analysts have revised their coverage, including Truist’s analysts, who increased its forecast for the stock in early November from “a Hold” to “a Buy”. SVB Securities began covering CORT with “Market perform” recommendation on April 11, 2023. Piper Sandler started covering the stock on April 04, 2023. It rated CORT as “an Overweight”.
Price Performance Review of CORT
On Tuesday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock jump 1.23% to $80.76. Over the last five days, the stock has gained 3.92%. Corcept Therapeutics Inc shares have risen nearly 37.82% since the year began. Nevertheless, the stocks have risen 60.27% over the past one year. While a 52-week high of $117.33 was reached on 03/31/25, a 52-week low of $49.00 was recorded on 01/13/25.
Levels Of Support And Resistance For CORT Stock
The 24-hour chart illustrates a support level at 78.71, which if violated will result in even more drops to 76.67. On the upside, there is a resistance level at 82.28. A further resistance level may holdings at 83.81.
How much short interest is there in Corcept Therapeutics Inc?
A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on 2025-11-14, dropping by 73152.0 shares to a total of 10.17 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 10.24 million shares. There was a decline of -0.72%, which implies that there is a negative sentiment for the stock.
